SANOFI CONSUMER HEALTHCARE INDIA
|
The Current P/E Ratio of SANOFI CONSUMER HEALTHCARE INDIA is 66.62.
Share Price | ₹4,875.0 | May 09,2025 |
Market Cap | ₹11,212.4 Cr | |
Earnings-TTM | ₹168.3 Cr | TTM-Standalone Results |
Price/Earnings | 66.62x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of SANOFI CONSUMER HEALTHCARE INDIA
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹11,212.4 Cr] as on May 09,2025
(/) Earnings [ ₹168.3 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 66.62x ]
Thus, for SANOFI CONSUMER HEALTHCARE INDIA , the investors are currently willing to pay 66.62 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of SANOFI CONSUMER HEALTHCARE INDIA !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of SANOFI CONSUMER HEALTHCARE INDIA over the last five years.
Historical PE (Price/Earnings) ratio chart of SANOFI CONSUMER HEALTHCARE INDIA
PE Ratio Performance Analysis for SANOFI CONSUMER HEALTHCARE INDIA
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio for fiscal years ending Dec2024 to Dec2023 averaged 31.31x.
- SANOFI CONSUMER HEALTHCARE INDIA 's operated at median p/e ratio of 62.61x from fiscal years ending March 2018 to 2022.
- Looking back at the last 2 fiscal years, SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio peaked in Dec2024 at 62.61x.
- SANOFI CONSUMER HEALTHCARE INDIA 's p/e ratio hit its five-year low in Dec2023 of 0x.
How does SANOFI CONSUMER HEALTHCARE INDIA 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
SANOFI CONSUMER HEALTHCARE INDIA | 168.30 | 66.62 | 11,212.4 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 36.45 | 418,648.0 |
DIVIS LABORATORIES LTD | 2,067.00 | 77.07 | 159,310.0 |
CIPLA LTD | 5,000.43 | 23.88 | 119,410.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 57.03 | 106,189.0 |
DR REDDYS LABORATORIES LTD | 5,703.50 | 16.92 | 96,496.4 |
MANKIND PHARMA LTD | 2,050.73 | 48.55 | 99,569.6 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 19.24 | 88,337.3 |
LUPIN LTD | 2,892.10 | 32.17 | 93,051.6 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.31 | 67,585.0 |
ABBOTT INDIA LTD | 1,334.46 | 48.01 | 64,061.6 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs SANOFI CONSUMER HEALTHCARE INDIA 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 16.92x |
Max industry PE | 77.07x |
Median industry PE | 36.45x |
Average industry PE | 40.48x |
You may also like the below Video Courses